Understanding how programmed cell death works in various diseases
Molecular Mechanisms of Programmed Necrosis Execution
This study is looking at a special way cells can die that might help us understand and improve treatments for diseases like cancer and COVID-19 by focusing on a protein called MLKL, which is important in this process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10928092 on NIH RePORTER |
What this research studies
This research investigates the process of necroptosis, a type of programmed cell death that does not involve caspases, which is important in several diseases including cancer and COVID-19. The study focuses on the molecular mechanisms that activate a protein called MLKL, which plays a crucial role in this cell death process. By examining how MLKL is modified and activated, the research aims to uncover new insights that could lead to better treatments for conditions associated with necroptosis. Patients may benefit from advancements in therapies targeting these mechanisms.
Who could benefit from this research
Good fit: Ideal candidates include individuals suffering from cancers, COVID-19, or other diseases associated with necroptosis.
Not a fit: Patients with conditions unrelated to necroptosis or those not affected by the diseases being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases linked to necroptosis, improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding programmed cell death mechanisms, suggesting potential for breakthroughs in this area.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Najafov, Ayaz — Ut Southwestern Medical Center
- Study coordinator: Najafov, Ayaz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.